Atomoxetine Does Not Require Tapering
Atomoxetine can be discontinued abruptly without tapering. The FDA label explicitly states that "Atomoxetine capsules can be discontinued without being tapered" 1. This is a clear, definitive recommendation from the regulatory authority based on systematic evaluation during the drug's clinical development program.
Evidence Supporting Abrupt Discontinuation
The safety of abrupt atomoxetine discontinuation was rigorously evaluated in prospective, placebo-controlled studies involving both children and adults with ADHD. After 9-10 weeks of continuous atomoxetine therapy, patients who abruptly discontinued showed:
- No discontinuation syndrome: The incidence of discontinuation-emergent adverse events was low, with no statistically significant differences between patients stopping atomoxetine versus those continuing on placebo 2
- No symptom rebound: While ADHD symptoms worsened after discontinuation (expected return of underlying condition), they did not rebound beyond pretreatment baseline levels 2
- Well-tolerated discontinuation: Atomoxetine discontinuation was well tolerated across all age groups studied 2, 3
Key Mechanistic Distinction
Unlike antidepressants (which commonly cause withdrawal symptoms and often require tapering 4), atomoxetine's norepinephrine reuptake inhibition does not produce clinically significant neuroregulatory changes that manifest as withdrawal symptoms upon discontinuation 2. This fundamental pharmacological difference explains why tapering is unnecessary.
Practical Clinical Implications
- Patients can miss occasional doses without rebound effects or discontinuation syndrome 5
- Switching medications: When transitioning from atomoxetine to another ADHD medication, abrupt discontinuation is appropriate 5
- Blood pressure and heart rate: Any increases during atomoxetine treatment return to baseline upon discontinuation without requiring gradual reduction 6
- Adverse event resolution: Common adverse events resolve within 3-53 days after stopping, regardless of whether discontinuation is abrupt or gradual 6
Important Caveat
While tapering is not necessary for safety reasons, the FDA label recommends that physicians "periodically reevaluate the long-term usefulness of the drug for the individual patient" 1. This refers to planned medication holidays or trials off medication to assess ongoing need—not a requirement for gradual dose reduction when stopping.
Bottom line: Atomoxetine is unique among ADHD medications in that it can be stopped immediately without tapering, making it particularly convenient for medication trials, switches, or definitive discontinuation 1, 2.